Corticosteroid allergy in a patient with systemic lupus erythematosus.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D001706:Biopsy; D003231:Conjunctivitis / Q000188:drug therapy; D004247:DNA / Q000096:biosynthesis; D003872:Dermatitis / Q000188:drug therapy; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000150:complications* / Q000209:etiology*; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects / Q000494:pharmacology; D066298:In Vitro Techniques; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D008263:Macrophage Migration-Inhibitory Factors / Q000096:biosynthesis; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects / Q000494:pharmacology; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010612:Pharyngitis / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects; D012882:Skin Tests; D013748:Tetracaine / Q000009:adverse effects; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000305:Adrenal Cortex Hormones; D008263:Macrophage Migration-Inhibitory Factors; D009883:Ophthalmic Solutions; D013748:Tetracaine; D014316:Tritium; D003907:Dexamethasone; D004247:DNA; D011241:Prednisone; D013936:Thymidine; D006854:Hydrocortisone; D008775:Methylprednisolone